Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$68.8M |
| 2 |
Netflix
NFLX
|
+$67.7M |
| 3 |
JPMorgan Chase
JPM
|
+$59.1M |
| 4 |
Visa
V
|
+$54.4M |
| 5 |
Shell
SHEL
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$684M |
| 2 |
Willis Towers Watson
WTW
|
+$95.9M |
| 3 |
Intercontinental Exchange
ICE
|
+$67.8M |
| 4 |
M&T Bank
MTB
|
+$63.8M |
| 5 |
Avantor
AVTR
|
+$50.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.34% |
| 2 | Technology | 12.67% |
| 3 | Industrials | 8.71% |
| 4 | Consumer Discretionary | 7.41% |
| 5 | Healthcare | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
MSC Industrial Direct
MSM
$6.66B
| $1.53M | 0.01% |
+18,000
| New | +$1.46M |
|
|
BLU
827
DELISTED
BELLUS Health Inc.
BLU
| $1.53M | 0.01% |
222,956
-94,192
| -30% | -$607K |
|
828
ABM Industries
ABM
$2.75B
| $1.53M | 0.01% |
+33,300
| New | +$1.45M |
|
|
ABB
829
DELISTED
ABB Ltd
ABB
| $1.53M | 0.01% |
47,400
-7,600
| -14% | -$265K |
|
|
FPAC
830
DELISTED
Far Peak Acquisition Corporation
FPAC
| $1.52M | 0.01% |
152,900
-31,500
| -17% | -$313K |
|
831
Bank of Hawaii
BOH
$3.03B
| $1.52M | 0.01% |
+18,100
| New | +$1.56M |
|
832
Kodiak Sciences
KOD
$2.34B
| $1.52M | 0.01% |
+196,800
| New | +$7.68M |
|
|
LVACU
833
DELISTED
LAVA Medtech Acquisition Corp. Unit
LVACU
| $1.52M | 0.01% |
149,997
-46,269
| -24% | -$468K |
|
|
RETA
834
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.52M | 0.01% |
+46,300
| New | +$1.37M |
|
|
GSQD
835
DELISTED
G Squared Ascend I Inc.
GSQD
| $1.51M | 0.01% |
153,500
-2,000
| -1% | -$19.7K |
|
836
Algoma Steel
ASTL
$424M
| $1.51M | 0.01% |
+134,300
| New | +$1.33M |
|
837
Shake Shack
SHAK
$3.05B
| $1.51M | 0.01% |
+22,200
| New | +$1.53M |
|
838
Dropbox
DBX
$7.58B
| $1.51M | 0.01% |
64,800
-26,400
| -29% | -$615K |
|
|
IMDX
839
Insight Molecular Diagnostics
IMDX
$141M
| $1.51M | 0.01% |
50,535
-1,040
| -2% | -$33.3K |
|
840
Hilltop Holdings
HTH
$2.22B
| $1.5M | 0.01% |
+50,900
| New | +$1.66M |
|
841
Kemper
KMPR
$1.63B
| $1.5M | 0.01% |
+26,467
| New | +$1.47M |
|
|
ALE
842
DELISTED
Allete
ALE
| $1.49M | 0.01% |
+22,206
| New | +$1.43M |
|
843
Trupanion
TRUP
$1.39B
| $1.48M | 0.01% |
+16,621
| New | +$1.53M |
|
844
Devon Energy
DVN
$53.1B
| $1.47M | 0.01% |
+24,900
| New | +$1.35M |
|
845
The Greenbrier Companies
GBX
$1.43B
| $1.47M | 0.01% |
+28,500
| New | +$1.28M |
|
846
CACI
CACI
$14.1B
| $1.47M | 0.01% |
+4,867
| New | +$1.34M |
|
847
Ormat Technologies
ORA
$6.48B
| $1.45M | 0.01% |
17,707
+14,982
| +550% | +$1.1M |
|
|
GBT
848
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.44M | 0.01% |
41,579
-51,961
| -56% | -$1.55M |
|
849
Community Bank
CBU
$3.32B
| $1.42M | 0.01% |
+20,300
| New | +$1.48M |
|
850
Yeti Holdings
YETI
$3.14B
| $1.42M | 0.01% |
23,700
+16,870
| +247% | +$1.09M |
|
Similar funds
Steve Schonfeld's Q1 2022 Portfolio in Review
As of Q1 2022, Steve Schonfeld held 3,171 positions worth $11.1B, up 0.79% from $11B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Steve Schonfeld deployed $606M of net new capital in Q1 2022, opening 1,089 new positions and adding to 590 existing holdings. Its largest new stake was Visa: 251,517 shares worth $55.8M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $684M trimmed.
- Steve Schonfeld's largest Q1 2022 buy was Visa: 251,517 shares worth $55.8M.
- Steve Schonfeld added most to Bank of New York Mellon in Q1 2022, an estimated $68.8M increase.
- Steve Schonfeld's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $684M.
- Steve Schonfeld fully exited FedEx in Q1 2022, selling an estimated $48M.
- Steve Schonfeld's ten largest holdings make up 20% of its $11.1B portfolio in Q1 2022.
- Steve Schonfeld opened 1,089 new positions and closed 624 in Q1 2022.
- Steve Schonfeld's portfolio value rose 0.79% quarter-over-quarter to $11.1B.
Based on Schonfeld Strategic Advisors's 13F filing for Q1 2022, filed 16 May 2022.